🇺🇸 FDA
Pipeline program

METFORAL 850 mg compresse rivestite con film

BREAKFAST

Phase 2 small_molecule active

Quick answer

METFORAL 850 mg compresse rivestite con film for Triple negative breast cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Triple negative breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials